RxDoctor Payments Data

Brandon Kusako

Surgical · Darien, CTNPI 1831798362

Payments from drug & device makers

$2,121in general payments, 2019–2025

Across 41 payments — averaging $51.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$492
  • Tactile Systems Technology Inc$264
  • CSL Behring$239
  • Stryker$189
  • Endologix LLC$184
  • Veryan Medical Incorporated$150
  • plus $604 from 15 others

What the payments were for

  • Food & beverage$2,121100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,121 in reported general payments places this provider in the 85th percentile of 568 surgical providers in Connecticut.

See all surgical providers in Connecticut

Medicare billing

Part B allowed, 2024
$3,234
Medicare patients
19
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban74$91,848
EliquisApixaban65$50,989
ClopidogrelClopidogrel Bisulfate19$323
Atorvastatin Calcium21$186
Cefadroxil24$174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$19$91,84874 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 568 surgical providers in Connecticut.

Other surgical in Darien

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →